Characterization of the Human Proteomic Response to Hydrocodone: A Preliminary Study

Abstract

Non-medical use and abuse of prescription opioids is a growing problem in both the civilian and military communities. Current technologies for detecting hydrocodone use are limited. Standard drug screens do not detect hydrocodone. In order to detect the use of hydrocodone and prescription opioids for non therapeutic purposes, it is vital to establish the excretion profile of these drugs. Currently there is no data available describing blood, urine and oral fluid profiles following administration of a 10 mg dose of hydrocodone. We will measure proteomes and metabolites in blood, urine and oral fluid samples after hydrocodone exposure. We are exposing healthy volunteers (n = 30) to 10 mg pure hydrocodone under controlled conditions and collecting blood, oral fluid, and urine at defined intervals up to 7 days. We will include 2 subjects for control in the study giving a total of 32 participants.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Mar 01, 2012
Accession Number
ADA559675

Entities

People

  • Vikhyat S Bebarta

Tags

DTIC Thesaurus Topics

  • Afghanistan Conflict
  • Brain
  • Brain Injuries
  • Chromatography
  • Data Analysis
  • Data Sets
  • Department Of Defense
  • Drug Abuse
  • Drug Abuse Therapy
  • Institutional Review Board
  • Liquid Chromatography
  • Lysergic Acids
  • Mass Spectrometry
  • Medical Personnel
  • Opioids
  • Rodents
  • Spectrometry

Fields of Study

  • Medicine

Readers

  • Analytical Chemistry
  • Oncology and Biomarker-Based Cancer Detection.
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

  • Biotechnology
  • Fully Networked C3
  • Fully Networked C3 - Command and Control